Overview
- Neuroendocrine Cancer UK published new analysis highlighting prolonged diagnostic delays and urging faster pathways.
- Almost half of patients are not diagnosed at their first referral, and 16% return more than 10 times before receiving answers.
- Clinicians report that late detection reduces treatment options and increases physical and emotional harm.
- Recorded rates rose 371% between 1995 and 2018, with more than 6,000 people affected each year in England.
- Symptoms vary widely and are frequently misattributed to conditions such as irritable bowel syndrome, asthma or menopause, according to experts and patient accounts.